The Long Run with Luke Timmerman Ep178: Peyton Greenside on ML-Guided Biologics Discovery
16 snips
May 13, 2025 Peyton Greenside, co-founder and CEO of BigHat Biosciences, is revolutionizing biologic drug discovery using machine learning. She shares her journey from math enthusiast to CEO, emphasizing the vital role mentorship plays for women in STEM. The discussion dives into how AI and innovative techniques are speeding up antibody design, and the challenges of securing investor confidence in a skeptical industry. With a vision for the future, Greenside reveals how successful early projects can spur rapid advancements in therapeutic development.
AI Snips
Chapters
Transcript
Episode notes
Kilimanjaro Expedition Experience
- Peyton Greenside joined a Kilimanjaro expedition last minute and found the experience inspirational and memorable.
- The expedition team was assembled before she joined, and it helped build strong personal connections.
Computational Biology Combining Passions
- Peyton loved both math and biology but discovered computational biology as a great way to combine them.
- This emerging field allowed her to apply math and computer science to understand biology and disease.
Support Empowers Women in STEM
- Encouragement and mentors are critical for women in math and STEM fields, overcoming feelings of isolation.
- Personal support from family and teachers makes pursuing science in male-dominated fields possible.